HOME >> BIOLOGY >> NEWS
Antibiotic identified as potential anti-cancer candidate

A molecular mechanism that was formerly thought to be important only in bacteria has now been shown to be a potential target for an anticancer therapy based on antibiotic use. David Scheinberg and colleagues, at the Sloan-Kettering Institute, have been investigating an enzyme in humans that is similar to one in bacteria called peptide deformylase (Pdf) and have found that an antibiotic called actinonin, which inhibits the human Pdf, also inhibits tumor growth. Pdf was thought to be important only to bacteria and the bacterially-related organelles of cells of higher organisms. Pdf is an enzyme that, during protein production, removes a modification called an N-formyl group from the first amino acid, a methionine, in the protein chain. While work began on the development of antibiotics against what was thought to be a bacterial-exclusive enzyme, genome-based data searches identified several classes of Pdf-like sequences in parasites, plants and mammals. Subsequent studies showed that the Pdfs were active both in culture and in the living organism, thus potentially derailing the usefulness of these antibiotics for specifically combating infectious agents. In previous studies, Scheinberg and colleagues had found that actinonin had an antiproliferative effect on human cancer cell lines and on tumor growth in a mouse model. They theorized this growth inhibitory activity might be related to actinonin's inhibition of human Pdf. The researchers now provide the evidence to support this theory. They show that human Pdf is active in the mitochondria and is essential for cellular growth and proliferation. They have designed and created a class of new actinonin-based Pdf inhibitors, and have demonstrated that they selectively inhibit growth in several human tumor cell lines. They further demonstrate that human tumor growth in mice can be suppressed by these Pdf inhibitors and suggest a mechanism of actinonin action. Taken together, these data have significant implicat
'"/>

Contact: Laurie Goodman
press_releases@the-jci.org
212-342-4159
Journal of Clinical Investigation
15-Oct-2004


Page: 1 2

Related biology news :

1. Antibiotic stress, genetic response and altered permeability of E. coli
2. Antibiotic treats lymphoma of the eye
3. Antibiotic inhibits cancer gene activity
4. Antibiotic resistance markers in GM plants not a risk to human health
5. Antibiotics may not be enough to stop recurrent gastric lymphoma caused by Helicobacter pylori
6. Antibiotics help combat dangerous tropical disease
7. Antibiotic resistant bacterium uses Sonar-like strategy to see enemies or prey
8. Antibiotic-resistant bacteria increased after clindamycin use for common vaginal infection
9. Link identified between Alzheimers disease and glaucoma
10. Gene identified for Crohns disease in children
11. New gene mutation identified in common type of dementia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/14/2019)... Va. (PRWEB) , ... November 13, 2019 , ... ... today that Robert Peterson, RAC , a regulatory affairs and program management ... the biopharmaceutical and medical device industries, has joined the firm as an Expert ...
(Date:11/12/2019)... IRVINE, Calif. (PRWEB) , ... November 12, 2019 ... ... an open call for proposals from nonprofit U.S. universities and research institutions for ... grant will provide support of up to $1.2 million per site for the ...
(Date:11/7/2019)... ... ... R3 Stem Cell is now offering its comprehensive Online Stem Cell ... use during checkout is FIFTYOFF and applies to both the one month access and ... with over 12,000 successful stem cell procedures performed nationwide. A couple years ago, R3 ...
Breaking Biology News(10 mins):
(Date:12/4/2019)... United Kingdom (PRWEB) , ... December 03, 2019 ... ... of recombinant antibody products and services, today announced a partnership with the Recombinant ... Chicago, University of Toronto, and UC San Francisco (UCSF) with a common goal ...
(Date:12/2/2019)... ... December 02, 2019 , ... Registration is now open ... which will be held at the Hynes Convention Center May 12-15, 2020, in Boston. ... and brings together scientists, physicians, patient advocates, and other stakeholders with the goal of ...
(Date:11/19/2019)... (PRWEB) , ... November 19, 2019 , ... ... cloud services provider of deep learning infrastructure solutions for Autonomous Vehicle , ... Graphcore Intelligence Processing Unit (IPU) systems with the Graphcore Poplar® software stack as ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... to educate Americans about the deadly healthcare-associated infection C. diff. The campaign, ... of the epidemic, which kills at least 30,000 people in the U.S. each ...
Breaking Biology Technology:
Cached News: